StockData
Adaptive Biotechnologies Corp logo

Adaptive Biotechnologies Corp (ADPT) income statement

ADPTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 12/30
$27.93−0.12 (-0.43%)

Close on Nov 20, 2026Market cap $4.46BP/E –Yield –

Adaptive Biotechnologies Corp financial ratios

See a number that looks wrong?